Jena Nimri
Rheumatology Physician · Houston, TX
Jena Nimri is a rheumatology physician with a practice address in Houston, Texas, and NPI 1811425341, issued on May 29, 2017. Check the license (Texas T1493, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Jena Nimri
- Primary taxonomy
- Rheumatology Physician 207RR0500X
- License number
- T1493 TX
Self-reported in NPPES; status is on the state search - Practice location
- 7200 Cambridge St, Houston, TX 77030
- Phone
- (405) 543-9030
- Enumerated
- May 29, 2017
- Record last updated
- Jan 24, 2024
- Medicare enrollment
- Enrolled (PECOS I20230512001492); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest rheumatology physician records → All 545 in Texas → Look up another NPI →
Also registered at 7200 Cambridge St
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Wasif Abidi, M.D., PH.D.Gastroenterology Physician1821230780
- Layla Abushamat, M.D., M.P.H.Endocrinology, Diabetes & Metabolism Physician1114306669
- Suneal Agarwal, MDGastroenterology Physician1720242324
- Shahnaj Alam, PT, DPTPhysical Therapist1730999509
- Sehrish Ali, D.O.Nephrology Physician1275944290
- Adrish Anand, MDNeurological Surgery Physician1194578674
Verify Jena Nimri in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license T1493Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
72% fewer Medicare Part D claims than the average rheumatology physician in 2024
549 Medicare Part D claims for 148 beneficiaries, against an average of 1,978 among the 6,301 providers of this specialty who prescribed in Part D.
Most prescribed
- Hydroxychloroquine Sulfate74 claims
- Prednisone61 claims
- Methotrexate34 claims
- Meloxicam29 claims
- Duloxetine Hcl23 claims
- Leflunomide23 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $346.97
24 payments; by number, the most common kind was food and beverage; the largest payer was Abbvie Inc. The 4,486 providers of this specialty with any payment received $8,538.33 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through 2 group practices
- Baylor College OF MedicineHouston, TX
- Baylor College OF MedicineHouston, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Jena Nimri among 545 rheumatology physician records in Texas
Jena Nimri is one of 545 rheumatology physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2017, is newer than 87% of them.
- NPI issued2017 · 87% of these records are older, 10% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 77% of these records are
- Graduated2015 · median 2004 among the 417 with a school on file
- Record last updated2024 · 46% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RR0500X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Rheumatology Physician providers in Texas
There are 545 rheumatology physician records in Texas.
All 545 in Texas → Every provider in Houston → Rheumatology Physician nationwide →
The 8 rheumatology physician records with the nearest ZIP codes
- Sandeep AgarwalHouston, TX 770301467489757
- Frank Arnett, M.D.Houston, TX 770301922026152
- Shervin Assassi, M.D.Houston, TX 770301043259567
- Kalpana Bhairavarasu, M.DHouston, TX 770301942236682
- Holly Jones, M. D.Houston, TX 770301457344202
- Huifang Lu, M.D. PHDHouston, TX 770301487672879
- Maureen Mayes, M.D.Houston, TX 770301255364238
- John Reveille, M.D.Houston, TX 770301295753408
Common questions
What is Jena Nimri's NPI number?
Jena Nimri's National Provider Identifier (NPI) is 1811425341, issued on May 29, 2017. An NPI identifies a provider in billing; it is not a license.
Where is Jena Nimri located?
The NPPES record lists a practice address at 7200 Cambridge St, Houston, TX, 77030. Phone: (405) 543-9030. Providers update this record themselves, so call before visiting.
How can I verify Jena Nimri's license?
NPPES lists Texas license number T1493, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Jena Nimri prescribe under Medicare Part D?
In 2024, Jena Nimri had 549 Medicare Part D claims for 148 beneficiaries; the average among rheumatology physician prescribers was 1,978. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.